Cassava Sciences Announces Initiation of an Open-Label Study to Evaluate PTI-125 in Patients with Alzheimer's Disease

Author's Avatar
Mar 25, 2020
Article's Main Image

Approximately 100 Study Participants Will Receive PTI-125 For 12 Months